The effects of PLGA microparticles on intestinal absorption of p-glycoprotein substrate using the everted rat intestinal sac model

Archives of Pharmacal Research

Volumn 34, Issue 11, 2011, Pages 1989-1997

  Derakhshandeh, Katayoun ^a,b   Hosseinalizadeh, Aidin ^a,b   Nikmohammadi, Maryam ^a,b  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Everted intestinal sac; Furosemide; Microparticles; P glycoprotein; PLGA

Indexed keywords

FUROSEMIDE; GLYCOPROTEIN P; POLYGLACTIN; VERAPAMIL;

ANIMAL EXPERIMENT; ARTICLE; CHROMATOGRAPHY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG PENETRATION; DRUG TRANSPORT; ENCAPSULATION; INTESTINE ABSORPTION; MICROPARTICLE ENZYME IMMUNOASSAY; NONHUMAN; RAT;

ANIMALS; CELL MEMBRANE PERMEABILITY; CELL POLARITY; DIURETICS; DRUG CARRIERS; DRUG COMPOUNDING; FUROSEMIDE; INTESTINAL ABSORPTION; JEJUNUM; KINETICS; LACTIC ACID; MALE; MEMBRANE TRANSPORT MODULATORS; MICROSPHERES; OSMOLAR CONCENTRATION; P-GLYCOPROTEIN; PHYSICOCHEMICAL PHENOMENA; POLYGLYCOLIC ACID; RATS; RATS, WISTAR; SUBSTRATE SPECIFICITY;

EID: 83655191879     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-011-1120-1     Document Type: Article

References (43)

1. J. M. Aceves R. Cruz E. Hernandez 2000 Preparation and characterization of Furosemide-Eudragit controlled release systems Int. J. Pharm. 195 45 53 10675682 10.1016/S0378-5173(99)00303-8 1:CAS:528:DC%2BD3cXhtV2hs7k%3D (Pubitemid 30089489)
2. B. J. Aungst 1993 Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism J. Pharm. Sci. 82 979 987 8254497 10.1002/jps.2600821002 1:CAS:528: DyaK3sXmslynt7o%3D (Pubitemid 23314099)
3. B. J. Aungst 2000 Intestinal permeation enhancers J. Pharm. Sci. 89 429 442 10737905 10.1002/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO;2-J 1:CAS:528:DC%2BD3cXis12ktbw%3D
4. P. V. Balimane Y. H. Han S. Chong 2006 Current industrial practices of assessing permeability and P-glycoprotein interaction AAPS J. 8 E1 E13 16584115 10.1208/aapsj080101 1:CAS:528:DC%2BD28XjsVCisL4%3D (Pubitemid 43116028)
5. M. Ballent A. Lifschitz G. Virkel J. Sallovitz C. Lanusse 2006 Modulation of the P-glycoprotein-mediated intestinal secretion of ivermectin: in vitro and in vivo assessments Drug Metab. Dispos. 34 457 463 16381664 1:CAS:528:DC%2BD28Xit1Sgt7o%3D (Pubitemid 43290904)
6. T. Bansal G. Mishra M. Jaggi R. K. Khar S. Talegaonkar 2009 Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats Eur. J. Pharm. Sci. 36 580 590 19135530 10.1016/j.ejps.2008.12.005 1:CAS:528:DC%2BD1MXhs1aqurk%3D
7. L. Barthe M. Bessouet J. F. Woodley G. Houin 1998 The improved everted gut sac: a simple method to study intestinal P-glycoprotein Int. J. Pharm. 173 255 258 10.1016/S0378-5173(98)00225-7 1:CAS:528:DyaK1cXmt1eltrw%3D
8. L. Barthe J. F. Woodley S. Kenworthy G. Houin 1998 An improved everted gut sac as a simple and accurate technique to measure paracellular transport across the small intestine Eur. J. Drug Metab. Pharmacokinet. 23 313 323 9725499 10.1007/BF03189357 1:CAS:528:DyaK1cXlvVeitr0%3D (Pubitemid 28401125)
9. H. Beyers S. F. Malan J. G. van der Watt M. M. de Villiers 2000 Structure-solubility relationship and thermal decomposition of furosemide Drug Dev. Ind. Pharm. 26 1077 1083 11028222 10.1081/DDC-100100271 1:CAS:528:DC%2BD3cXnt12gu7w%3D
10. H. Bundgaard T. Nørgaard N. M. Nielsen 1988 Photodegradation and hydrolysis of furosemide and furosemide esters in aqueous solutions Int. J. Pharm. 42 217 224 10.1016/0378-5173(88)90178-0 1:CAS:528:DyaL1cXhvFaltb4%3D (Pubitemid 18092109)
11. K. Chan Z. Q. Liu Z. H. Jiang H. Zhou Y. F. Wong H. X. Xu L. Liu 2006 The effects of sinomenine on intestinal absorption of paeoniflorin by the everted rat gut sac model J. Ethnopharmacol. 103 425 432 16169700 10.1016/j.jep.2005.08. 020 1:CAS:528:DC%2BD28XovVSqsg%3D%3D (Pubitemid 43143379)
12. W. L. Chiou S. M. Chung T. C. Wu C. Ma 2001 A comprehensive account on the role of efflux transporters in the gastrointestinal absorption of 13 commonly used substrate drugs in humans Int. J. Clin. Pharmacol. Ther. 39 93 101 11396754 1:CAS:528:DC%2BD38XlsVamtg%3D%3D (Pubitemid 32208536)
13. S. M. Chung E. J. Park S. M. Swanson T. C. Wu W. L. Chiou 2001 Profound effect of plasma protein binding on the polarized transport of furosemide and verapamil in the Caco-2 model Pharm. Res. 18 544 547 11451044 10.1023/A:1011022931368 1:CAS:528:DC%2BD3MXkvFCnsb4%3D (Pubitemid 32592589)
14. K. Derakhshandeh M. Nikmohammadi A. Hosseinalizadeh 2011 Factorial effect of process parameters on pharmaceutical characteristics of biodegradable PLGA microparticles Int. J. Drug Deliv. 3 324 334 1:CAS:528:DC%2BC3MXnsVGiu78%3D
15. S. D. Flanagan L. Z. Benet 1999 Net secretion of furosemide is subject to indomethacin inhibition, as observed in Caco-2 monolayers and excised rat jejunum Pharm. Res. 16 221 224 10100306 10.1023/A:1018868123367 1:CAS:528:DyaK1MXhvFylsbg%3D (Pubitemid 29135125)
16. S. D. Flanagan C. L. Cummins M. Susanto X. Liu L. H. Takahashi L. Z. Benet 2002 Comparison of furosemide and vinblastine secretion from cell lines overexpressing multidrug resistance protein (P-glycoprotein) and multidrug resistance-associated proteins (MRP1 and MRP2) Pharmacology 64 126 134 11834888 10.1159/000056161 1:CAS:528:DC%2BD38XhtVCnsbo%3D (Pubitemid 34136853)
17. I. Gomez-Orellana 2005 Strategies to improve oral drug bioavailability Expert Opin. Drug Deliv. 2 419 433 16296764 10.1517/17425247.2.3.419 1:CAS:528:DC%2BD2MXlsFShsb4%3D (Pubitemid 41683218)
18. J. H. Hamman P. H. Demana E. I. Olivier 2007 Targeting receptors, transporters and site of absorption to improve oral drug delivery Drug Target Insights 2 71 81 21901064 1:STN:280:DC%2BC3MfitVemsg%3D%3D
19. S. Haznedar B. Dortunç 2004 Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide Int. J. Pharm. 269 131 140 14698584 10.1016/j.ijpharm.2003.09.015 1:CAS:528:DC%2BD3sXpvFekt74%3D (Pubitemid 38032830)
20. J. Hunter B. H. Hirst 1997 Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption Adv. Drug Deliv. Rev. 25 129 157 10.1016/S0169-409X(97)00497-3 1:CAS:528:DyaK2sXjsVKht74%3D (Pubitemid 27288486)
21. Jackson, E., Diuretics. In Goodman and Gilman's: the pharmacological base of therapeutics, 9th ed, Hardman, J., Limbird, L., Molinoff, P., Ruddon, R., and Gilman, G. (Eds.). McGraw-Hill, New York, pp. 685-713, (1996).
22. T. Jung W. Kamm A. Breitenbach E. Kaiserling J. X. Xiao T. Kissel 2000 Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? Eur. J. Pharm. Biopharm. 50 147 160 10840198 10.1016/S0939-6411(00)00084-9 1:CAS:528:DC%2BD3cXjslyisrs%3D (Pubitemid 30326694)
23. M. R. Kelly R. E. Cutler A. W. Forrey B. M. Kimpel 1974 Pharmacokinetics of orally administered furosemide Clin. Pharmacol. Ther. 15 178 186 4812154 1:CAS:528:DyaE2cXksFyhurc%3D
24. F. S. Kilic O. Batu B. Sirmagul E. Yildirim K. Erol 2004 Intestinal absorption of digoxin and interaction with nimodipine in rats Pol. J. Pharmacol. 56 137 141 15047988 1:CAS:528:DC%2BD2cXltV2ls70%3D (Pubitemid 38519060)
25. H. Kooshapur M. Chaideh 1999 Intestinal transport of human insulin in rat Med. J. Islamic Acad. Sci. 12 5 11
26. J. Kreuter 1991 Peroral administration of nanoparticles Adv. Drug Deliv. Rev. 7 71 86 10.1016/0169-409X(91)90048-H 1:CAS:528:DyaK3MXmtl2guro%3D
27. O. Lacombe J. Woodley C. Solleux J. M. Delbos C. Boursier-Neyret G. Houin 2004 Localisation of drug permeability along the rat small intestine, using markers of the paracellular, transcellular and some transporter routes Eur. J. Pharm. Sci. 23 385 391 15567292 10.1016/j.ejps.2004.09.002 1:CAS:528: DC%2BD2cXhtVamu7nJ (Pubitemid 39573390)
28. C. M. Laffont P. L. Toutain M. Alvinerie A. Bousquet-Mélou 2002 Intestinal secretion is a major route for parent ivermectin elimination in the rat Drug Metab. Dispos. 30 626 630 12019186 10.1124/dmd.30.6.626 1:CAS:528:DC%2BD38XktFSlsLg%3D (Pubitemid 34579093)
29. J. H. Lin M. Yamazaki 2003 Role of P-glycoprotein in pharmacokinetics: clinical implications Clin. Pharmacokinet. 42 59 98 12489979 10.2165/00003088-200342010-00003 1:CAS:528:DC%2BD3sXptVymuw%3D%3D (Pubitemid 36092258)
30. V. Ling L. H. Thompson 1974 Reduced permeability in CHO cells as a mechanism of resistance to colchicines J. Cell. Physiol. 83 103 116 4855907 10.1002/jcp.1040830114 1:CAS:528:DyaE2cXksVGqt78%3D
31. F. Maestrelli N. Zerrouk M. Cirri N. Mennini P. Mura 2008 Microspheres for colonic delivery of ketoprofenhydroxypropyl-â-cyclodextrin complex Eur. J. Pharm. Sci. 34 1 11 18359208 10.1016/j.ejps.2008.02.001 1:CAS:528:DC%2BD1cXlslyksbg%3D
32. M. F. Mahomoodally A. Gurib-Fakim A. H. Subratty 2007 Effect of exogenous ATP on Momordica charantia Linn. (Cucurbitaceae) induced inhibition of D-glucose, Ltyrosine and fluid transport across rat everted intestinal sacs in vitro J. Ethnopharmacol. 110 257 263 17092672 10.1016/j.jep.2006.09.020 1:CAS:528:DC%2BD2sXit1Gmsb4%3D (Pubitemid 46283659)
33. S. Majumdar A. K. Mitra 2006 Chemical modification and formulation approaches to elevated drug transport across cell membranes Expert Opin. Drug Deliv. 3 511 527 16822226 10.1517/17425247.3.4.511 1:CAS:528: DC%2BD28XmslSksrs%3D
34. Y. Masaoka Y. Tanaka M. Kataoka S. Sakuma S. Yamashita 2006 Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract Eur. J. Pharm. Sci. 29 240 250 16876987 10.1016/j.ejps.2006.06.004 1:CAS:528: DC%2BD28XhtFentr3N (Pubitemid 44602413)
35. T. Nassar A. Rom A. Nyska S. Benita 2009 Novel double coated nanocapsules for intestinal delivery and enhanced oral bioavailability of tacrolimus, a P-gp substrate drug J. Control. Release 133 77 84 18822327 10.1016/j.jconrel.2008. 08.021 1:CAS:528:DC%2BD1cXhsVKnurrN
36. C. A. Santos J. S. Jacob B. A. Hertzog B. D. Freedman D. L. Press P. Harnpicharnchai E. Mathiowitz 1999 Correlation of two bioadhesion assays: the everted sac technique and the CAHN microbalance J. Control. Release 61 113 122 10469908 10.1016/S0168-3659(99)00109-1 1:CAS:528:DyaK1MXlsFOku7Y%3D (Pubitemid 29406085)
37. F. J. Sharom 1997 The P-glycoprotein efflux pump: how does it transport drugs? J. Membr. Biol. 160 161 175 9425600 10.1007/s002329900305 1:CAS:528:DyaK2sXotV2isb4%3D (Pubitemid 28026729)
38. M. Takano R. Yumoto T. Murakami 2006 Expression and function of efflux drug transporters in the intestine Pharmacol Ther. 109 137 161 16209890 10.1016/j.pharmthera.2005.06.005 1:CAS:528:DC%2BD2MXht12ktbbP (Pubitemid 41740818)
39. S. Tandon M. Das S. K. Khanna 1993 Effect of sanguinarine on the transport of essential nutrients in an everted gut sac model: role of Na+, K+-ATPase Nat. Toxins. 1 235 240 8167940 10.1002/nt.2620010406 1:CAS:528:DyaK3sXksVejt7Y%3D (Pubitemid 23130103)
40. H. Thomas H. M. Coley 2003 Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein Cancer Control. 10 159 165 12712010 (Pubitemid 36437822)
41. N. W. Thomas P. G. Jenkins K. A. Howard M. W. Smith E. C. Lavelle J. Holland S. S. Davis 1996 Particle uptake and translocation across epithelial membranes J. Anat. 189 487 490 8982821 (Pubitemid 27011000)
42. M. V. Varma R. Panchagnula 2005 pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situ J. Pharm. Sci. 94 2632 2643 16258992 10.1002/jps.20489 1:CAS:528:DC%2BD2MXht12ktrjO (Pubitemid 43265387)
43. T. H. Wilson G. Wiseman 1954 The use of sacs of everted small intestine for the study of the transference of substances from the mucosal to the serosal surface J. Physiol. 123 116 125 13131249 1:STN:280:DyaG2c%2FltFWjtg%3D%3D